A third of transvaginal ultrasound exams were avoided by use of the high-frequency probe.
In patients with first trimester pain or bleeding, documentation of an intrauterine pregnancy is used as evidence of the absence of an ectopic pregnancy, given the rarity of heterotopic pregnancies (which occur in about 1/30,000 normal pregnancies and 1/4,000 assisted reproductive technology pregnancies). The standard approach is to obtain a transabdominal scan using the low-frequency curvilinear probe, and if no intrauterine pregnancy is visualized, to perform a transvaginal scan. Investigators from a single emergency department evaluated whether a high-frequency linear probe could be used to detect more intrauterine pregnancies transabdominally, thereby obviating the need for some transvaginal scans.
Of 81 women with first trimester pain o…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals